Research Overview

This combination preparation pairs CJC-1295 without DAC, a short-acting GHRH analog also referred to as Mod GRF (1-29), with ipamorelin, a selective agonist at the ghrelin receptor. The two constituents engage separate receptor systems, and such pairings have been examined in preclinical models of somatotroph signalling and pulsatile growth hormone release. The 10 mg size refers to the combined peptide content of the vial.

Quality & Testing

Every CJC-1295 No DAC + Ipamorelin Blend batch is independently verified by an accredited third-party laboratory using HPLC (High-Performance Liquid Chromatography) and mass spectrometry to confirm both purity and molecular identity. Every order number is tracked internally against the supply-chain testing for the batches it shipped from — we don’t publish batch documents, which are routinely copied by other vendors. For testing information relating to your order, contact us with your order number.

Handling & Storage

CJC-1295 No DAC + Ipamorelin Blend is supplied as a lyophilized (freeze-dried) powder. Store at -20°C and protect from light and moisture prior to reconstitution. For laboratory reconstitution volume and concentration calculations, see our Reconstitution Calculator.

Research Use Only. CJC-1295 No DAC + Ipamorelin Blend is sold exclusively for in-vitro laboratory and scientific research. It is not intended for human or veterinary use, is not a drug, food, or cosmetic, and has not been evaluated by Health Canada or the FDA.